# Outcome in Patients Treated with Intraarterial Thrombectomy - OptiMAL Blood Pressure Control (OPTIMAL-BP)

> **NCT04205305** · PHASE4 · COMPLETED · sponsor: **Yonsei University** · enrollment: 306 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** conventional blood pressure control (labetalol, nicardipine)
- **DRUG:** intensive blood pressure control (labetalol, nicardipine)

## Key facts

- **NCT ID:** NCT04205305
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-18
- **Primary completion:** 2023-07-23
- **Final completion:** 2023-07-23
- **Target enrollment:** 306 (ACTUAL)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04205305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04205305, "Outcome in Patients Treated with Intraarterial Thrombectomy - OptiMAL Blood Pressure Control (OPTIMAL-BP)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04205305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*